Literature DB >> 21116296

Tumor focality in prostate cancer: implications for focal therapy.

Markos Karavitakis1, Hashim U Ahmed, Paul D Abel, Steven Hazell, Mathias H Winkler.   

Abstract

In recent years, there has been a growing interest in focal treatment for prostate cancer. Although widely used for the treatment of tumors of the breast and kidney, focal treatment for prostate cancer remains a controversial area. Criticism of focal prostate therapy has been based on the fact that prostate cancer is a multifocal disease. Until now, little attention has been paid to distinguishing between men with unifocal and those with multifocal disease because such information has little clinical relevance when treatment is aimed at the whole gland irrespective of the volume or number of cancers in the prostate. In this Review, we summarize existing knowledge and examine the issue of prostate cancer focality in the context of focal treatment.

Entities:  

Mesh:

Year:  2010        PMID: 21116296     DOI: 10.1038/nrclinonc.2010.190

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  94 in total

Review 1.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

2.  Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

Authors:  Jonathan I Epstein; Harriete Sanderson; H Ballentine Carter; Daniel O Scharfstein
Journal:  Urology       Date:  2005-08       Impact factor: 2.649

3.  Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.

Authors:  I A Lubensky; L V Debelenko; Z Zhuang; M R Emmert-Buck; Q Dong; S Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; S J Marx; A M Spiegel; F S Collins; L A Liotta
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

4.  Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.

Authors:  Erica H Lambert; Kimberly Bolte; Puneet Masson; Aaron E Katz
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

5.  Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer.

Authors:  Satoru Muto; Takashi Yoshii; Keisuke Saito; Yutaka Kamiyama; Hisamitsu Ide; Shigeo Horie
Journal:  Jpn J Clin Oncol       Date:  2008-02-15       Impact factor: 3.019

6.  Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors.

Authors:  A Villers; J E McNeal; F S Freiha; T A Stamey
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

Review 7.  Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

Authors:  Hashim Uddin Ahmed; Mark Emberton
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

Review 8.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Authors:  Scott E Eggener; Peter T Scardino; Peter R Carroll; Michael J Zelefsky; Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Samson W Fine; John Trachtenberg; Mark A Rubin; Mak Ohori; Kentaro Kuroiwa; Michel Rossignol; Lucien Abenhaim
Journal:  J Urol       Date:  2007-10-15       Impact factor: 7.450

Review 9.  Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.

Authors:  C Obek; P Louis; F Civantos; M S Soloway
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

10.  Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer.

Authors:  A Hügel; N Wernert
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  24 in total

Review 1.  Robotic prostate biopsy and its relevance to focal therapy of prostate cancer.

Authors:  Henry Ho; John S P Yuen; Christopher W S Cheng
Journal:  Nat Rev Urol       Date:  2011-09-20       Impact factor: 14.432

Review 2.  Image-guided robotic interventions for prostate cancer.

Authors:  Ashwin N Sridhar; Archie Hughes-Hallett; Erik K Mayer; Philip J Pratt; Philip J Edwards; Guang-Zhong Yang; Ara W Darzi; Justin A Vale
Journal:  Nat Rev Urol       Date:  2013-06-18       Impact factor: 14.432

3.  Temporal changes in the pathologic assessment of prostate cancer.

Authors:  M Scott Lucia; Adrie van Bokhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

Review 4.  Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.

Authors:  Drew Moghanaki; Baris Turkbey; Neha Vapiwala; Behfar Ehdaie; Steven J Frank; Patrick W McLaughlin; Mukesh Harisinghani
Journal:  Semin Radiat Oncol       Date:  2016-08-31       Impact factor: 5.934

Review 5.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

Review 6.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

Review 7.  Skp2: a novel potential therapeutic target for prostate cancer.

Authors:  Zhiwei Wang; Daming Gao; Hidefumi Fukushima; Hiroyuki Inuzuka; Pengda Liu; Lixin Wan; Fazlul H Sarkar; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2011-09-22

Review 8.  Can we deliver randomized trials of focal therapy in prostate cancer?

Authors:  Hashim U Ahmed; Viktor Berge; David Bottomley; William Cross; Rakesh Heer; Richard Kaplan; Tom Leslie; Chris Parker; Clare Relton; Richard Stephens; Matthew R Sydes; Lindsay Turnbull; Jan van der Meulen; Andrew Vickers; Timothy Wilt; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2014-04-22       Impact factor: 66.675

Review 9.  Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer.

Authors:  Charles Meyer; Bing Ma; Lakshmi P Kunju; Matthew Davenport; Morand Piert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-16       Impact factor: 9.236

Review 10.  A biomedical engineering approach to mitigate the errors of prostate biopsy.

Authors:  Hashim Uddin Ahmed; Mark Emberton; Gordon Kepner; Jeremy Kepner
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.